Use of an Immunoglobulin G Avidity Test To Discriminate between Primary and Secondary Dengue Virus Infections

Journal of Clinical Microbiology

Volumn 42, Issue 4, 2004, Pages 1782-1784

  De Souza, Vanda Akico Ueda Fick ^a   Fernandes, Silvana ^a   Araújo, Evaldo Stanislau ^b   Tateno, Adriana Fumie ^a   Oliveira, Olímpia M N P F ^b   Dos Reis Oliveira, Renato ^a   Pannuti, Cláudio Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ANA COSTA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; DENGUE; DENGUE VIRUS; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN G AVIDITY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

DENGUE VIRUS; RNA VIRUSES;

EID: 16544366643     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.4.1782-1784.2004     Document Type: Article

References (29)

1. Baccard-Longere, M., F. Freymuth, D. Cointe, J. M. Seigneurin, and L. Grangeot-Keros. 2001. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin. Diagn. Lab. Immunol. 8:429-431.
2. Blackburn, N. K., T. G. Besselaar, B. D. Schoub, and K. F. O'Connell. 1991. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J. Med. Virol. 33:6-9.
3. Burke, D. S., A. Nisalak, D. E. Johnson, and R. M. Scott. 1988. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38:172-180.
4. Enders, G., and F. Knotel. 1989. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 4:218-226.
5. Gray, J. J. 1995. Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation. J. Virol. Methods 52:95-104.
6. Gubler, D. J. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480-496.
7. Guzmán, M. G., G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, and L. Morier. 1990. Dengue hemorrhagic fever in Cuba. Am. J. Trop. Med. Hyg. 42:179-184.
8. Guzmán, M. G., and G. Kouri. 2002. Dengue: an update. Lancet Infect. Dis. 2:33-42.
9. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
10. Halstead, S. B., and E. J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:201-217.
11. Hedman, K., and S. A. Rosseau. 1989. Measurement of avidity of specific IgG for verification of recent primary rubella. J. Med. Virol. 27:288-292.
12. Hedman, K., M. Lappalainen, M. Söderlund, and L. Hedman. 1993. Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol. 4:123-129.
13. Innis, B. L., A. Nisalak, S. Nimmannitya, S. Kusalerdchariya, V. Chongswasdi, S. Suntayaborn, P. Puttisri, and C. H. Hoke. 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40:418-427.
14. Inouye, S., A. Hasegawa, S. Matsuno, and S. Katow. 1984. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J. Clin. Microbiol. 20:525-529.
15. Kliks, S. C., S. Nimmannitya, A. Nisalak, and D. S. Burke. 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38:411-419.
16. Kliks, S. C., A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40:444-451.
17. Meurman, O., M. Waris, and K. Hedman. 1992. Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection. J. Clin. Microbiol. 30:1479-1484.
18. Paunio, M., K. Hedman, I. Davidkin, M. Valle, O. P. Heinonen, P. Leinikki, and H. Peltola. 2000. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol. Infect. 124:263-271.
19. Paunio, M., K. Hedman, I. Davidkin, and H. Peltola. 2003. IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy. Expert Opin. Pharmacother. 4:1215-1225.
20. Rigau-Perez, J. G., G. G. Clark, D. J. Gubler, P. Reiter, E. J. Sanders, and A. V. Vorndam. 1998. Dengue and dengue haemorrhagic fever. Lancet 352:971-977.
21. Söderlund, M., C. S. Brown, B. J. Cohen, and K. Hedman. 1995. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J. Infect. Dis. 171:710-713.
22. Souza, V. A. U. F., C. S. Pannuti, L. M. Sumita, and H. F. Andrade, Jr. 1997. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J. Med. Virol. 52:275-279.
23. Steiner, L. A., and H. N. Eisen. 1967. Sequential changes in the relative affinity of antibodies synthesized during the immune response. J. Exp. Med. 126:1161-1183.
24. Swetz, J. A. 1988. Measuring the accuracy of diagnostic systems. Science 240:1285-1293.
25. Thein, S., M. M. Aung, T. N. Shwe, M. Aye, A. Zaw, K. Aye, K. M. Aye, and J. Aaskov. 1997. Risk factors in dengue shock syndrome. Am. J. Trop. Med. Hyg. 56:566-572.
26. Thomas, H. I. J., and P. Morgan-Capner. 1991. The use of antibody avidity measurements for the diagnosis of rubella. Rev. Med. Virol. 1:41-50.
27. Tuokko, H. 1995. Detection of acute measles infections by indirect and μ-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J. Med. Virol. 45:306-311.
28. Vaughn, D. W., A. Nisalak, T. Solomon, S. Kalayanarooj, N. M. Dung, R. Kneen, A. Cuzzubbo, and P. L. Devine. 1999. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am. J. Trop. Med. Hyg. 60:693-698.
29. World Health Organization. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. World Health Organization, Geneva, Switzerland.